• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术后复发性非梗阻性胆管炎:患病率、危险因素及治疗

Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment.

作者信息

Choquet Anaïs, Sokal Aurélien, Dokmak Safi, Le Bot Audrey, Delahaye Fanny, Dembinski Jeanne, Aussilhou Béatrice, Rebours Vinciane, de Lastours Victoire, Sauvanet Alain

机构信息

Department of HPB Surgery, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.

Department of Internal Medecine, AP-HP, Beaujon Hospital, University of Paris-Cité, Clichy, France.

出版信息

World J Surg. 2025 Sep;49(9):2570-2577. doi: 10.1002/wjs.70037. Epub 2025 Aug 7.

DOI:10.1002/wjs.70037
PMID:40776530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12435610/
Abstract

BACKGROUND

Recurrent nonobstructive cholangitis (RNOC) due to enterobiliary reflux is a late complication of pancreaticoduodenectomy (PD) that should be differentiated from obstructive cholangitis. The risk factors (RFs) of RNOC are poorly known. The goal of this study was to estimate the prevalence, to identify the RF, and to describe the management of RNOC following PD.

METHODS

This case-control study included 503 patients from a prospective database (2014-2018) who underwent PD; one hundred and eighty-three patients were excluded because they had less than 1-year of follow-up, tumor recurrence during postoperative year one, or cholangitis from anastomotic stenosis or tumor recurrence. RNOC was defined as at least 3 episodes of cholangitis that occurred or persisted more than 1-year after PD, without anastomotic stenosis or tumor recurrence. RF were identified by univariate and multivariate analyses.

RESULTS

Of the 320 analyzed patients, 213 (67%) and 107 (33%) underwent PD for malignancy and a benign lesion, respectively. With a median follow-up of 47 months (IQR: 33-68), 27 of the 320 patients (8%) developed RNOC (median number of episodes = 8 and IQR = 5-12). The only independent RF for RNOC was noninvasive IPMN (OR = 3.222; IC-95% = 1.219-8.514; and p = 0.018). All patients received on-demand antibiotics. Three patients (11%) developed complications from RNOC (hepatic abscesses in 3 and organ failure in one). No patients died from RNOC. Two (7%) patients underwent reoperation to lengthen the biliary Roux-en-Y loop but RNOC persisted in both.

CONCLUSIONS

RNOC complicates 8% of PD. Noninvasive IPMN was a RF of RNOC. The value of revision surgery to limit the risk of recurrence seems limited.

摘要

背景

因肠胆反流导致的复发性非梗阻性胆管炎(RNOC)是胰十二指肠切除术(PD)的一种晚期并发症,应与梗阻性胆管炎相鉴别。RNOC的危险因素尚不清楚。本研究的目的是评估RNOC的患病率,确定其危险因素,并描述PD术后RNOC的治疗方法。

方法

本病例对照研究纳入了前瞻性数据库(2014 - 2018年)中接受PD手术的503例患者;183例患者因随访时间不足1年、术后第1年出现肿瘤复发或因吻合口狭窄或肿瘤复发导致胆管炎而被排除。RNOC定义为PD术后至少发生3次胆管炎发作或持续超过1年,且无吻合口狭窄或肿瘤复发。通过单因素和多因素分析确定危险因素。

结果

在320例分析患者中,分别有213例(67%)和107例(33%)因恶性肿瘤和良性病变接受了PD手术。中位随访时间为47个月(四分位间距:33 - 68个月),320例患者中有27例(8%)发生了RNOC(发作次数中位数 = 8次,四分位间距 = 5 - 12次)。RNOC唯一的独立危险因素是非侵袭性胰腺导管内乳头状黏液性肿瘤(OR = 3.222;95%置信区间 = 1.219 - 8.514;p = 0.018)。所有患者均接受按需使用抗生素治疗。3例患者(11%)出现了RNOC相关并发症(3例发生肝脓肿,1例发生器官衰竭)。无患者死于RNOC。2例(7%)患者接受了再次手术以延长胆肠Roux - en - Y袢,但2例患者的RNOC仍持续存在。

结论

8%的PD患者会并发RNOC。非侵袭性胰腺导管内乳头状黏液性肿瘤是RNOC的一个危险因素。通过再次手术来降低复发风险的价值似乎有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7920/12435610/e813659cf62c/WJS-49-2570-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7920/12435610/578d3bd0408f/WJS-49-2570-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7920/12435610/e813659cf62c/WJS-49-2570-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7920/12435610/578d3bd0408f/WJS-49-2570-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7920/12435610/e813659cf62c/WJS-49-2570-g003.jpg

相似文献

1
Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment.胰十二指肠切除术后复发性非梗阻性胆管炎:患病率、危险因素及治疗
World J Surg. 2025 Sep;49(9):2570-2577. doi: 10.1002/wjs.70037. Epub 2025 Aug 7.
2
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
What Is the Cumulative Incidence of Femoral Stem Revision and Stem Complication in Cemented and Uncemented Hip Arthroplasty for Proximal Femoral Metastatic Bone Disease?对于股骨近端转移性骨病,骨水泥型和非骨水泥型髋关节置换术中股骨柄翻修及柄并发症的累积发生率是多少?
Clin Orthop Relat Res. 2025 Jun 10. doi: 10.1097/CORR.0000000000003541.
6
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
7
What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?改良杯笼技术治疗骨盆不连续性的功能、影像学和生存结果如何?
Clin Orthop Relat Res. 2024 Dec 1;482(12):2149-2160. doi: 10.1097/CORR.0000000000003186. Epub 2024 Jul 9.
8
Postoperative nutritional support after pancreaticoduodenectomy in adults.成人胰十二指肠切除术后的营养支持
Cochrane Database Syst Rev. 2025 Mar 14;3(3):CD014792. doi: 10.1002/14651858.CD014792.pub2.
9
Composite Reconstruction With Irradiated Autograft Plus Total Hip Replacement After Type II Pelvic Resections for Tumors Is Feasible but Fraught With Complications.肿瘤Ⅱ型骨盆切除术后采用同种异体骨移植加全髋关节置换术进行复合重建是可行的,但并发症多。
Clin Orthop Relat Res. 2024 Oct 1;482(10):1825-1835. doi: 10.1097/CORR.0000000000003097. Epub 2024 Apr 26.
10
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.

本文引用的文献

1
Late cholangitis after pancreatoduodenectomy: A common complication with or without anatomical biliary obstruction.胰十二指肠切除术后迟发性胆管炎:一种常见的并发症,与解剖性胆道梗阻有关或无关。
Surgery. 2024 Oct;176(4):1207-1214. doi: 10.1016/j.surg.2024.06.044. Epub 2024 Jul 25.
2
Towards a 'step-up approach' for the treatment of recurrent non-stenotic cholangitis after hepaticojejunostomy: systematic review.迈向肝肠吻合术后复发性非狭窄性胆管炎治疗的“阶梯式方法”:系统评价。
HPB (Oxford). 2024 Sep;26(9):1114-1122. doi: 10.1016/j.hpb.2024.05.018. Epub 2024 May 30.
3
Recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy: incidence and risk factors.
非狭窄性胆肠吻合术后患者复发性胆管炎:发生率及危险因素。
HPB (Oxford). 2024 Apr;26(4):558-564. doi: 10.1016/j.hpb.2024.01.003. Epub 2024 Jan 7.
4
Whipple Resection for Benign Tumors and Premalignant Neoplasms of the Pancreatic Head: Surgery-Associated Risk for Complications and Late Metabolic Morbidity Matters.胰头良性肿瘤和癌前肿瘤的Whipple切除术:手术相关的并发症风险和晚期代谢并发症至关重要。
Ann Surg Open. 2023 Aug 24;4(3):e325. doi: 10.1097/AS9.0000000000000325. eCollection 2023 Sep.
5
Risk Factors for Recurrence of Cholangitis After Pancreaticoduodenectomy and Comparison of Stents in Hepaticojejunostomy.胰十二指肠切除术后胆管炎复发的危险因素及肝肠吻合术内支架的比较。
World J Surg. 2023 Oct;47(10):2499-2506. doi: 10.1007/s00268-023-07104-3. Epub 2023 Jul 13.
6
Risk Factors for Cholangitis After Pancreatoduodenectomy: A Systematic Review.胰十二指肠切除术后胆管炎的危险因素:系统评价。
Dig Dis Sci. 2023 Jul;68(7):3158-3166. doi: 10.1007/s10620-023-07929-x. Epub 2023 Apr 6.
7
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.FOLFIRINOX 对比吉西他滨作为胰腺癌辅助治疗的 5 年结果:一项随机临床试验。
JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829.
8
The clinical features of late postoperative cholangitis following pancreaticoduodenectomy brought on by conditions other than cancer recurrence: a single-center retrospective study.胰十二指肠切除术后非癌症复发相关因素导致的迟发性胆管炎的临床特征:单中心回顾性研究。
BMC Surg. 2022 Aug 5;22(1):301. doi: 10.1186/s12893-022-01752-3.
9
Clinical and microbiological characteristics of reflux cholangitis following bilio-enteric anastomosis.胆肠吻合术后反流性胆管炎的临床和微生物学特征。
Eur J Clin Microbiol Infect Dis. 2022 Aug;41(8):1139-1143. doi: 10.1007/s10096-022-04468-7. Epub 2022 Jul 18.
10
Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial.基于算法的护理与常规护理用于荷兰胰腺切除术后并发症的早期识别和管理:一项开放标签、全国性、阶梯式楔形整群随机试验。
Lancet. 2022 May 14;399(10338):1867-1875. doi: 10.1016/S0140-6736(22)00182-9. Epub 2022 Apr 28.